BEYONDBIO INC has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ASCENEURON SA, CROOKS PETER A and SHANGHAI FOCHON PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | United States | 3 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Israel | 1 | |
#10 | Russian Federation | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Min Changhee | 18 |
#2 | Park Changmin | 10 |
#3 | Kim Yongeun | 10 |
#4 | Oh Byungkyu | 10 |
#5 | Son Hoon Young | 8 |
#6 | Park Minyoung | 6 |
#7 | Nah Ki Hyun | 4 |
#8 | Nah Ki-Hyun | 4 |
#9 | Seo Jin Soo | 3 |
#10 | Seo Jin-Soo | 3 |
Publication | Filing date | Title |
---|---|---|
KR20210029694A | 2'-Amino-6-(2-amino-6-methylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol dihydrochloride and pharmaceutical composition comprising the same | |
KR20210029695A | 2'-Amino-6-(2-amino-6-(1-isopropylpiperidin-4-yl)-5-methylpyrimidin-4-yl)-3'-fluoro-[2,4'-bipyridin]-5-ol trihydrochloride and pharmaceutical composition comprising the same | |
KR20210029693A | 2,6-Bis-(2-aminopyrimidin-4-yl)pyridin-3-ol dihydrochloride and pharmaceutical composition comprising the same | |
KR20210029470A | Process for Preparing Pyrimidinyl Bipyridine Compound and Intermediate Therefor | |
BR112017016465A2 | heterocyclic compound and pharmaceutical composition comprising it |